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REM-Behavior Disorder
Ivia Rivera-Agosto and Anthony Izzo
Abstract
Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia 
exclusively occurring during REM sleep. Viewing this disorder through a 
neurologic lens can provide longitudinal context for patients and their treating 
physicians, given the well-known association of RBD with a specific group of 
neurodegenerative disorders: the alpha synucleinopathies. It is important to have 
a high degree of clinical suspicion, the ability to make an accurate diagnosis, 
manage the symptoms, and more importantly monitor the patient for evolution 
of possible underlying neurological pathology. This chapter will discuss aspects 
of the clinical history, physical examination, ancillary testing, and diagnostic 
criteria.
Keywords: rapid eye movement (REM), REM sleep behavior disorder (RBD), 
Parkinson’s disease (PD), alpha synucleinopathies, dementia with Lewy bodies (LBD)
1. Introduction
There are a variety of disorders that can manifest complex movements and 
behaviors that happen during sleep. REM behavior disorder (RBD) is one such 
disorder characterized by loss of physiologic REM muscle atonia and dream enact-
ment. Motor activity consists of highly complex, vigorous or violent dream enacting 
behaviors that are noticed when they result in injuries of the patient or their bed 
partner. Some behaviors include punching, kicking, jumping out of bed, and talk-
ing. If the patient is awoken they may recall an unpleasant dream of falling, being 
attacked or chased by either another person or an animal. The latter are common 
dream contents associated with RBD.
A disorder of the elderly, RBD onset occurs between the sixth and seventh 
decades [1], with an estimated prevalence of between 1 and 7.7% of the popula-
tion [2]. The true extent of this disorder is largely unknown [3]. The disease 
is male predominant [9]. Symptoms are thought to arise from underlying 
dysfunction of the brainstem structures that regulate REM sleep atonia, mostly 
located in the dorsal mesopontine tegmentum and ventromedial medulla [9]. 
Injury to these areas can occur in the setting of structural lesions (such as 
stroke or multiple sclerosis), medication side effects (seen with certain antide-
pressants and beta blockers), or neuronal loss from neurodegenerative disease. 
There is a known association between RBD and the group of neurodegenerative 
conditions classified as alpha synucleinopathies. RBD is considered a prodrome 
of these conditions and can be present years before other neurological symp-
toms become apparent, thus the importance of early diagnosis and subsequent 
monitoring [7].
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2. Diagnosis
Often RBD is a missed diagnosis, likely due to under reporting. While some 
patients have no recollection of their nighttime behaviors, others may simply not 
view these are abnormal. Obtaining an accurate clinical history then depends on 
corroborative information gathered from the patient’s bed partner, as they may wit-
ness the dream enactment behavior. Of note, spouses may comment on the patient’s 
night time behaviors being out of character as compared to how they behave during 
the daytime. For patients who do not have a regular bed partner, questions regard-
ing vivid dreams (specifically of being attacked or engaged in combat) and unex-
plained night time injuries such as falling out of bed should be explored.
Differential diagnoses for complex nocturnal behaviors can be divided into several 
categories (see Table 1) including: partial arousal parasomnias, nightmare disor-
der, sleep related respiratory disorders, sleep related movement disorders, seizure 
disorders, and psychiatric disease. Partial arousal parasomnias occur mostly from 
slow wave sleep (happening during the first half of the night as noted in Table 2) and 
pathophysiology is presumed to be an incomplete transition from sleep to wakeful-
ness [10]. These episodes consist of an arousal with associated disorientation and 
amnesia. Behaviors are quite primitive such as walking and eating. Episodes may be 
exacerbated by factors that increase the threshold for arousal (e.g. sleep deprivation, 
sedating medications). Confusional arousals are part of this category; however, these 
are rare in adults. As opposed to sleep walking and sleep related eating disorder, 
NREM parasomnias RBD
Occur in the first part of the night Occur in the second part of the night
Patient is amnestic of event Patient recalls the event
Variable duration (minutes or longer) Last seconds to minutes
Patient is difficult to arouse Patient easily arousable
Male predominance Male predominance
Provoked by sleep deprivation, stress Unprovoked
Higher prevalence among children Higher prevalence among older adults
Table 2. 
SWS parasomnias vs RBD.
Partial arousal parasomnias (arising from slow wave sleep):
• Sleep talking/somniloquy
• Sleep walking/somnambulism
• Night terrors
• Confusional arousals
• Sleep related eating disorder
Nightmares
Obstructive sleep apnea
Periodic limb movements of sleep
Nocturnal frontal lobe epilepsy
Nocturnal panic attacks
Sleep-related groaning (Catathrenia)
Table 1. 
Differential diagnoses of RBD.
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confusional arousals are associated with poor responsiveness and amnesia but during 
confusional arousals there is no ambulation. Nightmare disorder consists of recurrent 
awakenings during which the patient is able to recall a disturbing dream and experi-
ences associated intense emotions such as fear, anxiety, or sadness. It is important to 
note that in nightmares there is preservation of REM atonia, therefore body move-
ment is rare and the patient is fully alert after awakening (as opposed to a confusional 
arousal). Obstructive sleep apnea should be investigated if patient has a history notable 
for excessive daytime sleepiness. Periodic limb movements of sleep and other sleep 
fragmenting conditions may precipitate partial arousal parasomnias, which can be 
misinterpreted as RBD. Lastly, while parasomnias are largely a disorder of childhood, 
primary RBD (as described below) almost exclusively occurs in older adults.
Nocturnal frontal lobe epilepsy (NFLE) is one of the most important differential 
diagnosis for complex nocturnal behaviors that may mimic RBD (see Table 3) [11]. 
NFLE also presents with complex, exclusively nocturnal, bizarre behaviors; the 
hallmark of this disorder is that each episode is stereotyped (like with all epilep-
sies), where actions occurring during parasomnias or RBD are varied. The “classic” 
example is bicycling of the legs at night time out of sleep. Unlike RBD or para-
somnias, there is no particular predilection for a time of night for these seizures to 
occur. Similar to parasomnias (but unlike RBD), the patient will be amnestic to the 
events themselves. Preferred treatment for nocturnal frontal lobe epilepsy includes 
anticonvulsant agents such as carbamazepine, oxcarbazepine, and lamotrigine.
Once suspicion for RBD is raised, confirmatory polysomnogram (PSG) should 
be pursued as this will provide a definite diagnosis. A full attended polysomnogram 
set up includes: abbreviated electroencephalography leads, eye movement monitor-
ing, nasal airflow monitoring, oronasal thermistor, mental/submental EMG, snore 
sensor, single ECG lead, chest/abdomen respiratory effort belts, pulse oximetry, and 
bilateral tibialis anterior EMG monitoring. When testing for RBD additional moni-
toring includes surface electromyography (EMG) preferably of the upper extremities 
as lower extremity movements are less specific [4]. The most sensitive information 
is obtained from monitoring of the chin (mental/submental electrodes) and flexor 
digitorum superficialis. Diagnostic features on PSG include increased muscle activity 
on surface EMG, specifically of both the chin and upper extremities. Activity on 
EMG is categorized as tonic or phasic. Tonic activity lasts longer than 15 s, while pha-
sic activity is much shorter lasting less than 5 s. Typically, tonic activity is observed 
in the chin, while phasic activity is observed in both the chin and upper extremity 
EMG. Additionally, combined chin/arm activity should be present for at least 27% of 
a 30 s epoch (as per the International Classification of Sleep Disorders Guidelines). 
This is a highly specialized test and its interpretation relies on visual quantifica-
tion, therefore technical quality is of the utmost importance [8]. Performing a full 
NFLE RBD
Stereotyped asymmetric hypermotor behaviors of 
trunk or proximal extremities
Variable dream enacting behaviors in a self-defense 
manner including vocalizations
Short duration 5–60 s Duration is seconds to 2 min
Patient is amnestic to the event Patient recalls the event
Occurs from NREM stages Occurs during REM sleep
May have nightly clusters Rare, sporadic events
Age of onset first or second decade Age of onset fifth decade
Table 3. 
Nocturnal frontal lobe epilepsy vs RBD.
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18 channel EEG montage during routine diagnostic PSG can help rule out NFLE, 
especially if a complex behavior is captured on the PSG study night.
Diagnostic criteria as established by the International Classification of Sleep 
Disorders, Third Edition include [5]:
• Repeated episodes of sleep related vocalization and/or complex motor behaviors
• Behaviors are documented by polysomnogram to occur during REM sleep or 
based on clinical history of dream enacting behavior, are presumed to occur 
during REM sleep
• Polysomnogram demonstrates REM sleep without atonia
• Disturbance is not better explained by another sleep disorder, mental disorder, 
medication, or substance abuse.
3.  Primary rapid eye movement sleep behavior disorder 
(synucleinopathies)
Once diagnosed, RBD can be classified as primary (idiopathic) or secondary. 
Idiopathic RBD can be considered an early symptom of alpha synucleinopathies which 
include: Parkinson’s disease, Lewy Body Dementia and Multiple System Atrophy. The 
diagnosis of RBD can be made years before any other neurologic symptoms are identi-
fied. In 80% of cases RBD preceded the diagnosis of neurodegenerative disease (more 
easily recognized motor features), by a mean of 14 years [6]. There is evidence to 
suggest that patients with RBD and mild cognitive impairment will develop dementia 
in an interval of 5 years or less [8]. Other subtle potentially predictive biomarkers of 
RBD (see Table 4) include: olfactory loss/anosmia, autonomic dysfunction (ranging 
from sexual dysfunction to cardiovascular symptoms), color vision deficit, cognitive 
impairment, excessive daytime sleepiness, psychiatric disorders (such as anxiety, 
depression, psychosis, impulse control disorders), personality changes, dopamine dys-
function, and excessive EMG activity [6]. The pathophysiology and temporal relation 
between these symptoms and motor symptom onset is highly variable. Subsequent 
neurological examination may show subtle signs of Parkinsonism such as mild bra-
dykinesia, while neurocognitive testing can show evidence of memory and executive 
dysfunction. Neuroimaging is useful if dopamine transporter scan shows evidence of 
decreased dopamine uptake in the putamen. Electroencephalogram can show corti-
cal slowing as well [8]. Biopsy of the colon and submandibular gland in patients with 
idiopathic RBD has shown evidence of phosphorylated alpha synuclein deposits.
Anosmia
Autonomic dysfunction
Color vision deficit
Cognitive impairment
Excessive daytime sleepiness
Psychiatric disorders
Personality changes
Dopamine dysfunction
Excessive EMG activity
Table 4. 
Potential biomarkers of RBD.
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4.  Secondary rapid eye movement sleep behavior disorder 
(non-synucleinopathy)
Other causes of RBD include neurologic disorders stemming from structural 
lesions such as pontine stroke or multiple sclerosis plaques. This can also rarely 
occur in the setting of progressive supranuclear palsy, Alzheimer’s disease, and 
Huntington disease among others. RBD can coexist with narcolepsy in 50% of 
patients. Medications that can precipitate RBD include antidepressants such as 
selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake 
inhibitors (SNRIs), tricyclics, and monoamine oxidase inhibitors (MAOi). Some 
beta blockers have also been identified as culprits.
5. Treatment
Symptomatic management of RBD should be approached from multiple angles. 
First, maintaining a safe sleep environment for the patient by removing objects 
that can inflict harm or lowering the bed closer to the floor. Bed partners may also 
opt for sleeping in separate bed for their own safety. Co-sleeping is an important 
part of intimacy, however, and this can continue by advising the patient to sleep in 
a sleeping bag on top of the bed shared with their loved one. Bed alarms to warn 
loved ones about the patient exiting the bed can also be helpful in reducing night 
time injuries associated with RBD.
Medical management with melatonin or low dose benzodiazepines such 
as clonazepam has been shown to reduce the dream enacting behaviors. 
Benzodiazepines are thought to work by suppressing REM sleep. Theoretically, 
other REM suppressant medications (including SSRIs, TCAs, selective SNRIs) 
may also help, given their mechanism of action. However there are no trials sup-
porting or refuting their efficacy and some may precipitate RBD as previously 
mentioned. These medications do, however, have lower tolerance and abuse 
potential than benzodiazepines. These treatments do not modify the risk of 
progression to PD, MSA, or LBD. Dopaminergic agents have not been shown to 
reduce dream enactment behaviors but may help comorbid periodic limb move-
ments if present. In RBD cases refractory to conventional treatment, cholinester-
ase inhibitors such as rivastigmine (studied in one trial) and donepezil (several 
cases) have been noted to reduce the number of dream enactment episodes as 
reported by bed partners.
6. Ethical considerations
As stated previously, development of RBD can herald a diagnosis of potentially 
disabling neurological disorders by over a decade. While not every patient with 
primary RBD will go on to develop one of these conditions, we believe that patients 
should be informed of the association between RBD and the alpha synucleinopa-
thies and therefore their risk of developing one of these disorders. The discussion 
should be geared towards ensuring periodic follow up and reducing anxiety by 
answering any questions the patient may have on the subject. Serial neurologic 
exams, either comprehensive or focused on Parkinsonian features like tremor, 
rigidity, and bradykinesia should be performed. This can ensure early, effective 
treatment of motor and other non-motor symptoms that can positively impact 
patients’ quality of life.
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7. Conclusion
RBD is a complex night time behavior consisting of dream enactment due to the 
loss of physiologic REM muscle atonia. It can be classified as idiopathic, which is 
in many cases a non-motor symptom of the alpha synucleinopathies. This group of 
neurodegenerative illnesses includes Parkinson’s disease, Lewy body dementia, and 
multiple system atrophy. The importance of understanding REM sleep behavior 
disorder and its implications cannot be overstated. Clinical suspicion and appropri-
ate history taking, supports an early diagnosis and symptomatic management. More 
importantly, treating physicians are able to educate and monitor patients for the 
development motor symptoms suggestive of neurodegenerative disease. This win-
dow of opportunity allows for enrollment in clinical trials and emerging therapies. 
Secondary RBD related to structural lesions or medications is important to recog-
nize in order to discontinue the offending agent and decrease the risk of night time 
injury. Medical management with melatonin or clonazepam can reduce the episodes 
of dream enactment. Non-medical interventions such as ensuring a safe sleeping 
environment can help prevent injury.
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